Asthma Clinical Trial
Official title:
The Effects of Neuromuscular Electrical Stimulation to Muscle Strength, Functional Capacity and Quality of Life in Older Patients With Asthma: Randomized Controlled Trial
| NCT number | NCT04254159 |
| Other study ID # | ElifD |
| Secondary ID | |
| Status | Completed |
| Phase | N/A |
| First received | |
| Last updated | |
| Start date | December 5, 2019 |
| Est. completion date | May 22, 2020 |
| Verified date | February 2022 |
| Source | Yeditepe University |
| Contact | n/a |
| Is FDA regulated | No |
| Health authority | |
| Study type | Interventional |
The aim of the randomized controlled study is to investigate the effects of NMES superimposed on voluntary contraction combined with patient education and exercise training program in patients with chronic obstructive pulmonary disease.
| Status | Completed |
| Enrollment | 24 |
| Est. completion date | May 22, 2020 |
| Est. primary completion date | February 2, 2020 |
| Accepts healthy volunteers | No |
| Gender | All |
| Age group | 65 Years to 75 Years |
| Eligibility | Inclusion Criteria: 1. Having stable asthma 2. Participating to the study in a voluntary basis 3. Being 65 - 75 years old 4. Having 2 point or over score from "Modified Medical Research Council (MMRC)" Dyspnea Scale 5. Being motivated to participate and follow exercise program Exclusion Criteria: 1. Having an asthma exacerbation in a last month 2. Other respiratory problems 3. Ischemic heart disease 4. Congestive heart disease 5. Pacemaker 6. Acute Cor Pulmonale 7. Neurological Diseases 8. Osteoporosis 9. Smoking |
| Country | Name | City | State |
|---|---|---|---|
| Turkey | Kadiköy Municipality Social Life Center | Istanbul | Kadiköy |
| Lead Sponsor | Collaborator |
|---|---|
| Yeditepe University | Kadikoy Municipality Social Life Center |
Turkey,
| Type | Measure | Description | Time frame | Safety issue |
|---|---|---|---|---|
| Primary | Sit to Stand Test | Quadriceps muscle endurance will be evaluated with this test | 8 weeks | |
| Primary | Muscle Strength Test | Jtech Commander Power Track Muscle Testing Dynamometer, USA which quantifies muscle power will be used to assess the maximum voluntary contractions of quadriceps muscle in pound meter. | 8 weeks | |
| Primary | Six Minute Walking Test | Six-Minute Walking Test (6MWT) was used to evaluate functional capacity of volunteers. | 8 weeks | |
| Primary | Asthma Quality of Life Scale (AQOL) | Asthma quality of life questionnaire will utilize to assess quality of life of participants over two weeks prior to interview which is validated in Turkish population by Alpaydin et al. | 8 weeks | |
| Secondary | Modified Medical Research Council (MMRC) Dyspnea Scale | Perceived dyspnea which is any restrictions performing daily living activities will be measured by MMRC dyspnea scale. | 8 weeks | |
| Secondary | Physical Activity Questionnaire for Elderly (PASE) | We will assess the physical activity status of the oler patients with asthma by using Physical Activity Questionnaire for Elderly (PASE). | 8 weeks | |
| Secondary | Time Up and Go Test | Time Up and Go Test (TUG) will be used to evaluate the risk for falling in older patients with asthma. | 8 weeks | |
| Secondary | Pulmonary Function Test | Medical International Research Spirodoc® Spiro, Italy brand named spirometry will be used to evaluate pulmonary functions of volunteers. | 8 weeks | |
| Secondary | Respiratory Muscle Strength Testing | The Micro Medical Micro RPM, England respiratory pressure meter will be utilized to measure respiratory muscle strength. | 8 weeks |
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT04624425 -
Additional Effects of Segmental Breathing In Asthma
|
N/A | |
| Terminated |
NCT04410523 -
Study of Efficacy and Safety of CSJ117 in Patients With Severe Uncontrolled Asthma
|
Phase 2 | |
| Active, not recruiting |
NCT03927820 -
A Pharmacist-Led Intervention to Increase Inhaler Access and Reduce Hospital Readmissions (PILLAR)
|
N/A | |
| Completed |
NCT04617015 -
Defining and Treating Depression-related Asthma
|
Early Phase 1 | |
| Recruiting |
NCT03694158 -
Investigating Dupilumab's Effect in Asthma by Genotype
|
Phase 4 | |
| Terminated |
NCT04946318 -
Study of Safety of CSJ117 in Participants With Moderate to Severe Uncontrolled Asthma
|
Phase 2 | |
| Completed |
NCT04450108 -
Vivatmo Pro™ for Fractional Exhaled Nitric Oxide (FeNO) Monitoring in U.S. Asthmatic Patients
|
N/A | |
| Completed |
NCT03086460 -
A Dose Ranging Study With CHF 1531 in Subjects With Asthma (FLASH)
|
Phase 2 | |
| Completed |
NCT01160224 -
Oral GW766944 (Oral CCR3 Antagonist)
|
Phase 2 | |
| Completed |
NCT03186209 -
Efficacy and Safety Study of Benralizumab in Patients With Uncontrolled Asthma on Medium to High Dose Inhaled Corticosteroid Plus LABA (MIRACLE)
|
Phase 3 | |
| Completed |
NCT02502734 -
Effect of Inhaled Fluticasone Furoate on Short-term Growth in Paediatric Subjects With Asthma
|
Phase 3 | |
| Completed |
NCT01715844 -
L-Citrulline Supplementation Pilot Study for Overweight Late Onset Asthmatics
|
Phase 1 | |
| Terminated |
NCT04993443 -
First-In-Human Study to Evaluate the Safety, Tolerability, Immunogenicity, and Pharmacokinetics of LQ036
|
Phase 1 | |
| Completed |
NCT02787863 -
Clinical and Immunological Efficiency of Bacterial Vaccines at Adult Patients With Bronchopulmonary Pathology
|
Phase 4 | |
| Recruiting |
NCT06033833 -
Long-term Safety and Efficacy Evaluation of Subcutaneous Amlitelimab in Adult Participants With Moderate-to-severe Asthma Who Completed Treatment Period of Previous Amlitelimab Asthma Clinical Study
|
Phase 2 | |
| Completed |
NCT03257995 -
Pharmacodynamics, Safety, Tolerability, and Pharmacokinetics of Two Orally Inhaled Indacaterol Salts in Adult Subjects With Asthma.
|
Phase 2 | |
| Completed |
NCT02212483 -
Clinical Effectiveness and Economical Impact of Medical Indoor Environment Counselors Visiting Homes of Asthma Patients
|
N/A | |
| Recruiting |
NCT04872309 -
MUlti-nuclear MR Imaging Investigation of Respiratory Disease-associated CHanges in Lung Physiology
|
||
| Withdrawn |
NCT01468805 -
Childhood Asthma Reduction Study
|
N/A | |
| Recruiting |
NCT05145894 -
Differentiation of Asthma/COPD Exacerbation and Stable State Using Automated Lung Sound Analysis With LungPass Device
|